Home/Filings/4/0001628280-22-016871
4//SEC Filing

BRAENDER LORI J 4

Accession 0001628280-22-016871

CIK 0001398733other

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 5:26 PM ET

Size

6.9 KB

Accession

0001628280-22-016871

Insider Transaction Report

Form 4
Period: 2022-06-08
BRAENDER LORI J
Chief Legal Officer
Transactions
  • Purchase

    Common Stock

    2022-06-08$0.96/sh+13,761$13,21138,761 total
  • Purchase

    Warrant (Right to Buy)

    2022-06-08$0.13/sh+13,761$1,78913,761 total
    Exercise: $0.96From: 2022-12-08Exp: 2027-06-08Common Stock (13,761 underlying)
Footnotes (1)
  • [F1]Each share of common stock sold to the Reporting Person was sold together with one warrant to purchase one share of common stock at a price per share of $1.09 per share and warrant, of which the price per share of common stock was deemed to be $0.96 and the price per warrant was deemed to be $0.13.

Issuer

Aquestive Therapeutics, Inc.

CIK 0001398733

Entity typeother

Related Parties

1
  • filerCIK 0001752955

Filing Metadata

Form type
4
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 5:26 PM ET
Size
6.9 KB